Samsung Biologics makes $1.8 billion all-cash offer for Switzerland's PolyPeptide Group

CNBCJuly 20, 2026 at 8:04 AM

South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1. 46 billion Swiss francs ($1. 8 billion) for Switzerland's PolyPeptide Group.

This is a summary. For the full story, read the original article at CNBC.

Original source: CNBC

markets

Scared of the AI trade? Here are three investment themes Goldman Sachs is offering instead.

MarketWatchJuly 20, 2026 at 11:42 AM

markets

Tempus to acquire Personalis for $1.5 billion

Investing.comJuly 20, 2026 at 12:48 PM

markets

FIFA emerges as the $9 billion winner as the biggest, brashest World Cup ever draws to a close

CNBCJuly 20, 2026 at 5:45 AM

← Back to all articles

Related Articles

Scared of the AI trade? Here are three investment themes Goldman Sachs is offering instead.

Tempus to acquire Personalis for $1.5 billion

FIFA emerges as the $9 billion winner as the biggest, brashest World Cup ever draws to a close